The Efficacy of Posterior Subtenon Triamcinolone Acetonide Injection in Treatment of Irvine-Gass Syndrome

REFERENCES

• Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmic. 1953;36:599–600. doi:10.1016/0002-9394(53)90302-X.
   PubMed Web of Science ®Google Scholar
• Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966 Nov;76(5):646–661. doi:10.1001/archopht.1966.03850010648005.
   PubMedGoogle Scholar
• Wittpenn JR, Silverstein S, Heier J, et al. for Cystoid Macular Edema (ACME) Study Group. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. Oct 2008;146(4):554–560. doi:10.1016/j.ajo.2008.04.036.
   PubMed Web of Science ®Google Scholar
• Lobo CL, Faria PM, Soares MA, Bernardes RC, Cunha-Vaz JG. Macular alterations after small-incision cataract surgery. J Cataract Refract Surg. 2004 Apr;30(4):752–760. doi:10.1016/S0886-3350(03)00497-8.
   PubMed Web of Science ®Google Scholar
• Packer M, Lowe J, Fine H. Incidence of acute postoperative cystoid macular edema in clinical practice. J Cataract Refract Surg. 2012 Dec;38(12):2108–2111. doi:10.1016/j.jcrs.2012.07.029.
   PubMed Web of Science ®Google Scholar
• Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008;146:554–560. doi:10.1016/j.ajo.2008.04.036.
   PubMed Web of Science ®Google Scholar
• Ismail RA, Sallam A, Zambarakji HJ. Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. Eur J Ophthalmol. 2008 Nov-Dec;18(6):1011–1013. doi:10.5301/EJO.2008.2549.
   PubMed Web of Science ®Google Scholar
• Klamann A, Böttcher K, Ackermann P, Geerling G, Schargus M, Guthoff R. Intravitreal dexamethasone implant for the treatment of postoperative macular edema. Ophthalmologica. 2016;236(4):181–185. doi:10.1159/000448057.
   PubMed Web of Science ®Google Scholar
• Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg. 2008;34:70–75. doi:10.1016/j.jcrs.2007.08.021.
   PubMed Web of Science ®Google Scholar
• Young PW, Shea M. Pars plasma vitrectomy in the management of the irvine-gass syndrome. Can J Ophthalmol. Oct 1980;15(4):172–175.
   PubMed Web of Science ®Google Scholar
• Gonzalez-De la Rosa A, Navarro-Partida J, Altamirano-Vallejo JC, et al. Novel triamcinolone acetonide-loaded liposomes topical formulation for the treatment of cystoid macular edema after cataract surgery: A pilot study. Ocul Pharmacol Ther. 2019 Jan 7. doi:10.1089/jop.2018.0101.
   PubMed Web of Science ®Google Scholar
• Bradford JD, Wilkinson CP, Bradford RH Jr. Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina. 1988;8(3):161–164. doi:10.1097/00006982-198808030-00001.
   PubMed Web of Science ®Google Scholar
• Henderson BA, Kim JY, Ament CS. Clinical pseudophakic cystoid macular edema. Risk factor for development and duration after treatment. J Cataract Refract Surg. 2007;33:1550–1558. doi:10.1016/j.jcrs.2007.05.013.
   PubMed Web of Science ®Google Scholar
• Frost NA, Sparrow JM, Strong NP, Rosenthal AR. Vitreus loss in planned extracapsular cataract extraction does lead to a poorer visual outcome. Eye (Lond). 1995;9:446–451. doi:10.1038/eye.1995.104.
   PubMed Web of Science ®Google Scholar
• Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135:246–249. doi:10.1016/S0002-9394(02)01938-4.
   PubMed Web of Science ®Google Scholar
• Koutsandrea C, Moschos MM, Brouzas D, Loukianou E, Apostolopoulos M, Moschos M. Intraocular triamcionolone acetonide for pseudophakic cystoid macular edema; optical coherence tomography and multifocal electroretinography study. Retina. 2007;27:159–164. doi:10.1097/IAE.0b013e31802e3e5c.
   PubMed Web of Science ®Google Scholar
• Williams GA, Haller JA, Kuppermann BD, et al. Dexametasone posterior segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol. 2009;147:1048–1054. doi:10.1016/j.ajo.2008.12.033.
   PubMed Web of Science ®Google Scholar
• Mason JO 3rd, Albert MA Jr, Vail R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina. 2006;26:356–357. doi:10.1097/00006982-200603000-00018.
   PubMed Web of Science ®Google Scholar
• Querques G, Iaculli C, DelleNoci N. Intravitreal pegaptanib sodium for Irvine-Gass syndrome. Eur J Ophthalmol. 2008;18(1):138–141. doi:10.5301/EJO.2008.2549.
   PubMed Web of Science ®Google Scholar
• Deuter CM, Gelisken F, Stübiger N, Zierhut M, Doycheva D. Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm. 2011;19:216–218. doi:10.3109/09273948.2011.562341.
   PubMed Web of Science ®Google Scholar
• Wu L, Arevalo JF, Hernandez-Bogantes E, Roca JA. Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group. Int Ophthalmol. 2012 Jun;32(3):235–243. doi:10.1007/s10792-012-9559-8.
   PubMedGoogle Scholar
• Giganti M, Beer PM, Lemanski N, Hartman C, Schartman J, Falk N. Adverse events after intravitreal infliximab (Remicade). Retina. 2010 Jan;30(1):71–80. doi:10.1097/IAE.0b013e3181bcef3b.
   PubMed Web of Science ®Google Scholar
• Mayer WJ, Kurz S, Wolf A, et al. Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome. J Cataract Refract Surg. Sep 2015;41(9):1954–1961. doi:10.1016/j.jcrs.2015.10.025.
   PubMed Web of Science ®Google Scholar
• Kodjikian L, Bellocq D, Bodaghi B. Management of Irvine-Gass syndrome. J Fr Ophtalmol. 2017 Nov;40(9):788–792. doi:10.1016/j.jfo.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Bellocq D, Pierre-Kahn V, Matonti F, et al. Effectiveness and safety of dexametasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol. 2017;101:333–341.
   PubMed Web of Science ®Google Scholar
• Yüksel B, Uzunel UD, Kerci SG, Sağban L, Küsbeci T, Örsel T. Comparison of subtenon triamcinolone acetonide injection with topical nepafenac for the treatment of pseudophakic cystoid macular edema. Ocul Immunol Inflamm. 2017 Aug;25(4):513–519. doi:10.3109/09273948.2016.1147587.
   PubMed Web of Science ®Google Scholar
• Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-Tenon’s corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997 Dec;104(12):2003–2008. doi:10.1016/S0161-6420(97)30065-7.
   PubMed Web of Science ®Google Scholar
• Freeman WR, Green RL, Smith RE. Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol. Mar 15 1987;103(3 Pt 1):281–288.
   PubMed Web of Science ®Google Scholar
• Thomas ER, Wang J, Ege E, Madsen R, Hainsworth DP. Intravitreal triamcinolone acetonide concentration after subtenon injection. Am J Ophthalmol. 2006 Nov;142(5):860–861. doi:10.1016/j.ajo.2006.05.023.
   PubMed Web of Science ®Google Scholar
• Greenbaum S. Anesthesia for cataract surgery. In: Greenbaum S, ed. Ocular Anesthesia. Philadephia: Saunders; 1997:30–36.
   Google Scholar
• Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema. J Diabetes Complications. 2006 Jul-Aug;20(4):246–251. doi:10.1016/j.jdiacomp.2005.06.015.
   PubMed Web of Science ®Google Scholar
• Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand. 2003 Dec;81(6):648–652. doi:10.1046/j.1395-3907.2003.0146.x.
   PubMedGoogle Scholar
• Byun YS, Park YH. Complications and safety profile of posterior subtenon injection of triamcinolone acetonide. J Ocul Pharmacol Ther. 2009 Apr;25(2):159–162. doi:10.1089/jop.2008.0087.
   PubMed Web of Science ®Google Scholar